The Paediatric Adaptive Sepsis Platform Trial (PASSPORT) is a different type of study called an adaptive platform trial (APT). The platform allows researchers assess multiple treatments at the same time. The adaptations allow researchers to improve the treatments under investigation over time. PASS...See more
Headquarters:
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2025 (1 years)
Address:
MELBOURNE, AU
LOW
spending power